TrueBlue (TBI) EBIT (2009 - 2026)

TrueBlue (TBI) has reported EBIT for 18 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 60.49% year-over-year to -$1.2 million in Q2 2026; TTM through Jun 2026 was -$48.6 million, a 41.34% decrease from a year earlier, with the FY2025 full-year figure at -$46.6 million, up 49.73% from the prior year.
• EBIT was -$1.2 million for Q2 2026 at TrueBlue, up from -$17.8 million in the prior quarter.
• Over five years, EBIT peaked at $29.3 million in Q2 2022 and troughed at -$60.0 million in Q2 2024.
• A 5-year average of -$6.1 million and a median of -$6.2 million in 2023 frame the typical range for EBIT.
• Across the five-year window, EBIT slumped 814.58% in 2024 and surged 97.88% in 2025, its largest moves.
• Over 5 years, EBIT stood at $6.9 million in 2022, then tumbled by 225.77% to -$8.6 million in 2023, then fell by 20.61% to -$10.4 million in 2024, then tumbled by 182.84% to -$29.4 million in 2025, then surged by 96.05% to -$1.2 million in 2026.
• The last three EBIT figures came in at -$1.2 million (Q2 2026), -$17.8 million (Q1 2026), and -$29.4 million (Q4 2025), per Business Quant data.